• SENSEX 80,710.76
    -7.25 (--0.01%)
  • BANKNIFTY 54,114.55
    39.10 (+0.07%)
  • N S D L
    1,298.70 1,425.00(%)
  • Ola Electric
    59.38 39.58(%)
  • Netweb Technol.
    3,180.10 3,180.10(%)
  • Indus Towers
    341.75 444.45(%)
  • Vodafone Idea
    7.45 15.22(%)
  • Moschip Tech.
    258.25 279.00(%)
  • Godfrey Phillips
    11,150.00 11,462.00(%)
  • Vimta Labs
    902.85 902.85(%)
  • G M D C
    515.00 515.00(%)
  • Fiem Industries
    2,005.00 1,156.00(%)
  • One Mobikwik
    309.00 698.30(%)
  • Brainbees Solut.
    407.80 734.25(%)
  • Apollo Micro Sys
    298.65 88.10(%)
  • Avantel
    180.20 191.01(%)
  • Swiggy
    440.00 617.00(%)
  • TCS
    3,029.50 2,992.05(%)
  • Eternal Ltd
    334.40 334.40(%)
  • L&T Finance Ltd
    232.85 232.85(%)
  • Reliance Industr
    1,380.80 1,551.00(%)
  • Kross Ltd
    235.00 271.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Morepen Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Morepen
  • BSE Code : 2685.0
  • ISIN : INE083A01026
49.31 0 (-0.42%)
  • As on 07 Sep 2025 (EOD)

  • Today’s Low

    48.76

  • Today’s High

    50.00

  • Open

    49.60

  • Perv Close

    49.52

  • 52W Low

    42.00

  • 52W High

    100.90

Key Indicators

  • P/E(TTM)

    36.26

  • Mar.Cap (₹Cr.)

    2,701.96

  • Div & Yield %

    0.41

  • Book Value(₹)

    21.56

  • Debt-Equity Ratio

    -0.42

  • AGM Date

    05-Sep-2025

  • EPS

    1.36

  • P/E Ratio

    36.26

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    2,701.96

  • RONW (%)

    12.08

  • ROCE (%)

    16.12

Score Board

  • Equity (₹ in Cr.)

    109.59

  • BV (₹)

    21.60

  • Sales( ₹ in Cr.)

    1,554.54

  • NP (in Cr.)

    101.58

  • NP Var(%)

    -8.0

  • Div%

    10.0

  • CPS (₹)

    2.30

  • EPS (₹)

    1.90

  • Traded Value (₹ in Lakhs)

    2,701.96

  • 52 Week High

    100.90

  • 52 Week Low

    42.00

  • Price BSE

    49.0

  • Price NSE

    49.00

  • Market Capital( in Cr.)

    2,701.96

  • P/C Ratio

    21.30

  • P/E Ratio

    26.40

  • Price Vs.BV

    1.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,554.54 1,537.59 1,338.88 1,449.27 1,112.42 791.99
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,554.54 1,537.59 1,338.88 1,449.27 1,112.42 791.99
Other Income 15.72 12.57 5.76 10.24 11.77 9.42
Stock Adjustments 44.36 -5.13 -16.54 -1.74 41.98 7.58
Total Income 1,614.62 1,545.03 1,328.10 1,457.77 1,166.17 808.99
EXPENDITURE :            
Raw Materials 1,019.99 945.15 886.48 988.81 778.60 528.67
Power and Fuel Cost 40.62 34.09 23.78 18.93 13.00 12.56
Employee Cost 177.22 160.28 146.19 150.00 123.20 98.07
Other Manufacturing Expenses 52.15 44.19 33.81 23.39 13.57 10.54
Selling and Administration Expenses 134.27 163.47 111.62 87.90 82.36 73.37
Miscellaneous Expenses 21.23 23.47 43.19 49.36 31.30 11.89
Employee Benefit Expenses 177.22 160.28 146.19 150.00 123.20 98.07
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,445.48 1,370.64 1,245.08 1,318.39 1,042.03 735.10
Operating Profit 169.13 174.39 83.03 139.37 124.15 73.89
Interest 7.10 3.51 1.98 -7.37 1.79 1.97
Gross Profit 162.03 170.88 81.05 146.74 122.36 71.92
Depreciation 24.44 21.90 18.01 21.19 28.11 34.43
Profit Before Tax 137.59 148.98 63.04 125.55 94.25 37.49
Current Tax 31.28 38.48 16.60 22.00 0.00 5.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.73 -0.44 0.20 2.48 0.00 0.00
Reported Net Profit 101.58 110.94 46.24 101.06 94.25 32.33
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 101.58 110.94 46.24 101.06 94.25 32.33
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 328.20 217.27 171.03 74.96 -19.29 -51.62
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 5.00 0.00 0.00
P & L Balance carried down 429.78 328.20 217.27 171.03 74.96 -19.29
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.20 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.85 2.17 0.90 2.12 2.10 0.72
Earnings Per Share(Adj)-Unit Curr 1.85 2.17 0.90 2.12 2.10 0.72
Book Value 21.56 17.39 15.26 11.97 8.92 6.83
Book Value(Adj)-Unit Curr 21.56 17.39 15.26 11.97 8.92 6.83

Shareholding Pattern

  • Promoter Group

    35.65%

  • Public Share Holding

    64.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 154,129,838 28.13 154,129,838 11
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,241,750 7.53 41,241,750 24
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 195,371,588 35.65 195,371,588 35
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 60,000 0.01 60,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3,090,298 0.56 3,090,298 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,446,706 1.72 9,446,706 38
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5,143,530 0.94 5,143,530 4
Mutual Funds / UTI 13,803 0.00 13,803 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 17,754,337 3.24 17,754,337 49
2] Non Institution
Bodies Corporate 12,459,922 2.27 11,826,551 716
Clearing Members 794,645 0.15 794,645 63
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,258,814 1.32 7,257,157 3,233
Foreign Non Institution Other 38,533,120 7.03 38,533,120 3
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 32,364,984 5.91 27,547,089 110
Individuals holding nominal share capital up to Rs. 1 lakh 238,050,283 43.44 217,269,583 456,963
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 38,831 0.01 38,831 7
Others 0 0.00 0 0
Sub Total 334,827,774 61.11 308,594,151 461,096
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 547,953,699 100.00 521,720,076 461,180

Company Background

Morepen Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Morepen Laboratories Ltd
  • BSE Code : 2685.0
  • ISIN : INE083A01026

  • Incorporation Year

    1984

  • Registered Office

    Morepen Village
    Nalagarh Road Near Baddi, Solan,
    Himachal Pradesh-173205

  • Telephone

    91-01795-276201-03

  • FAX

    91-01795-276204

  • Chairman

    Sushil Suri

  • Managing Director

    Sushil Suri

  • Company Secretary

    Vipul Kumar Srivatava

  • Auditor

    S P Babuta & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Mas Services Limited
    T-34 2nd Floor,
    Okhla Industrial Are,Phase II
    Mumbai - New Delhi - 110020

Morepen Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Morepen Labs. 49.31 1,570.25 1,554.54 36.26 12.79
Abbott India 31,179.05 6,684.73 6,409.15 45.62 44.95
Astrazeneca Phar 9,088.15 1,756.92 1,716.29 123.92 32.94
P & G Health Ltd 6,465.40 944.52 934.17 35.70 40.23
Glaxosmi. Pharma 2,770.30 3,866.05 3,723.49 49.82 58.72
Cipla 1,553.30 20,029.57 19,044.85 23.21 21.40
Amrutanjan Healt 769.30 469.50 451.82 40.79 21.89
Guj. Themis Bio. 383.80 152.47 150.80 93.84 27.21
Fermenta Biotec. 334.60 442.21 430.53 11.10 17.61
Bliss GVS Pharma 156.00 703.42 667.20 23.32 9.16
Ambalal Sarabhai 32.39 19.33 4.04 16.96 2.10